If we are gong to grow we will need capital for rapid expansion, and the market will be chaper than outher sources.
Plenty of companies get listed without earnings, ask Twitter or most biotechs. OUr market cap is large enought o get listed..
Would have to be about 1:50 to get listed and leave some room for volatility
any expert here want to say why scientifically INO's approach is better?
Petit: Again, I believe that Advaxis' immunotherapies could be a disruptive innovation in immunotherapies.
In order to have an effective immunotherapy, four essential elements are needed.
1. Access to Antigen Presenting Cells (APCs) -cells that direct the immune response to the right target. Unlike autologous immunotherapies, our immunotherapies do not require that you remove the dendritic cells and process them in a laboratory and make each person's cells their own treatment. Our immunotherapy vector meets the dendritic cells where they are, inside the patient and therefore one treatment can be used for every patient.
2. A strong cytotoxic T-cell response against tumor antigens is required. Advaxis immunotherapies generate a strong T-cell response to clear Listeria that is redirected to the tumor via the secreted antigens.
3. The ability to over-ride something called "Checkpoint Inhibitors" and "negative regulators" of cellular immunity is required. These checkpoint inhibitors are something utilized by cancerous masses to neutralize the immune response. Acute "perceived" listeriosis stimulates a maximum immune response that over-rides the checkpoint inhibitors.
4. The ability to over-ride Treg and MDSCs within tumor microenvironment, enabling killer T cells to kill tumor cells is required. Advaxis immunotherapies generate specific T-cells that access the protected tumor microenvironment and suppress immune protective cells within the tumor.
Other immunotherapies are trying to accomplish these elements through targeting specific aspects of this chain of components, however, to our knowledge, Advaxis' platform technology is the only immunotherapy that integrates all of these element into a comprehensive, single, well-tolerated, easy to manufacture and administer immunotherapy.
It is both acceptable and standard practice in both socialism and islam to lie without any compunction as long as it helps you get what you want.
Cash cow? Its bleeding red like a slaughtered pig!
Very interesting... Hayward gets 50 million options at .097 on October 17, and the stock is pumped to .14 the following week. Hayward can unload for a quick $2,150,000 bonus. Nice work if you can get it.